Sign in

CIK 0001651308 · Large accelerated filer

BeOne Medicines Ltd.

Sign in to watch
Ticker
BEIGF
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
981209416
Phone
41-616851900
Business address
C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
Former names
BeiGene, Ltd.

Securities

  • ONC American Depositary Shares Nasdaq
  • BEIGF Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$48,487,541
in 9 filings, $47.8M under 10b5-1 plans

Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Wang Xiaodong −$46.8M Director sold 100% of stake
  2. Lee Chan Henry −$865K SVP, General Counsel sold 100% of stake
  3. Ball Titus B. −$679K Principal Accounting Officer sold 100% of stake
  4. Wu Xiaobin −$106K President and COO sold 100% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-08-21 OYLER JOHN Chief Executive Officer Sale −694 $243.48 $169K 0
2020-08-20 OYLER JOHN Chief Executive Officer Sale −1,000 $230.16 $230K 20,523
2020-08-20 OYLER JOHN Chief Executive Officer Sale −2,500 $231.15 $578K 18,023
2020-08-20 OYLER JOHN Chief Executive Officer Sale −2,000 $232.34 $465K 16,023
2020-08-20 OYLER JOHN Chief Executive Officer Sale −600 $233.13 $140K 15,423
2020-08-20 OYLER JOHN Chief Executive Officer Sale −4,798 $234.45 $1.1M 10,625
2020-08-20 OYLER JOHN Chief Executive Officer Sale −3,845 $235.22 $904K 6,780
2020-08-20 OYLER JOHN Chief Executive Officer Sale −2,101 $236.50 $497K 4,679
2020-08-20 OYLER JOHN Chief Executive Officer Sale −4,679 $237.44 $1.1M 0
2020-08-20 AMGEN INC 10% owner Grant or award +64,176 $234.99 $15.1M 18,341,417
2020-08-19 OYLER JOHN Chief Executive Officer Sale −3,401 $232.36 $790K 26,465
2020-08-19 OYLER JOHN Chief Executive Officer Sale −4,403 $233.35 $1.0M 22,062
2020-08-19 OYLER JOHN Chief Executive Officer Sale −9,741 $234.24 $2.3M 12,321
2020-08-19 OYLER JOHN Chief Executive Officer Sale −6,221 $235.23 $1.5M 6,100
2020-08-19 OYLER JOHN Chief Executive Officer Sale −4,800 $236.32 $1.1M 1,300
2020-08-19 OYLER JOHN Chief Executive Officer Sale −1,300 $237.04 $308K 0
2020-08-19 AMGEN INC 10% owner Grant or award +64,176 $234.88 $15.1M 18,277,241
2020-08-18 AMGEN INC 10% owner Grant or award +40,000 $230.18 $9.2M 18,213,065
2020-08-14 OYLER JOHN Chief Executive Officer Sale −2,298 $209.55 $482K 6,407
2020-08-14 OYLER JOHN Chief Executive Officer Sale −2,817 $210.84 $594K 3,590

Page 83 of 99 · 1,972 trades